Fig. 2From: Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerUni- and multivariate analyses for DCB. Forest plots of univariate (A) and multivariate (B) analyses for DCB after ICI. The Odds Ratios are log10-transformedBack to article page